ACUTE RADIODERMATITIS DURING RADIATION THERAPY
Acute radiation skin toxicity is the most common of all radiation toxicities during radiotherapy. More than 90% of the patients receiving radiotherapy have some form of radiodermatitis. There are many risk factors for radiodermatitis. The most important symptom is pain. Modern treatment technics, such as intensity modulated radiotherapy (IMRT) are giving for decreased severity and incidence of radiodermatitis. In treatment of acute skin radiation toxicity are necessary pain management and adequate skin care.
Cancer Research UK. Available at: https://www.cancerresearchuk.org/health-professional/cancer-statistics/worldwide-cancer/incidence#heading-One (Accessed 17 March 2019).
Cognetta AB, Mendenhall WM (eds.). Radiation Therapy for Skin Cancer. Springer, New York, 2013.
Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys, 1995; 31: 1341–1346.
National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. Published: November 27, 2017. Available at: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_v5_quick_reference_5x7.pdf (Accessed 18 March 2019).
Robijns J, Laubach HJ. Acute and chronic radiodermatitis: clinical signs, pathophysiology, risk factors and management options. J Egypt women dermatol soc 2018; 15: 2-9.
Pazdur R, Camphausen KA, Wagman LD, Hoskins WJ. Cancer Management: A multidisciplinary approach. Cmp United Business Media. 7th ed, 2008.
Kole AJ, Kole L, Moran MS. Acute radiation dermatitis in breast cancer patients: challenges and solutions. Breast Cancer (Dove Med Press), 2017; 9: 313-23.
Seité S, Bensadoun RJ, Mazer JM. Prevention and treatment of acute and chronic radiodermatitis. Breast Cancer (Dove Med Press), 2017; 9: 551-557.
Copyright (c) 2019 The Serbian Chamber of Healthcare Institution
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.